Drugs

Regen BioPharma Scheduled to Make Presentation at American Society for Hematology''s 56th Annual Meeting in San Francisco December 6th - 9th

SAN DIEGO, CA: Dr. Christine Ichim to Discuss In Vivo Validation of Cancer Stem Cell Gene Target; Peer-Reviewed Support for NR2F6 (EAR-2) Nuclear Receptor Inhibition as a Means to "Kill Cancer at Its Root" ...

Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property

SAN DIEGO, CA: Company Aims to Use Small Molecule and Gene Silencing to Target "Root" of Cancer ...

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Pediatric Schizophrenia

PHOENIX, AZ: ...

Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic

BOTHELL, WA: SMARTICLES(R) Formulated MRX34 Was Found to Have a Manageable Safety Profile in Two Different Treatment Regimens ...

VANC Pharmaceuticals Receives NPNs From Health Canada For 4 Products

VANCOUVER, BRITISH COLUMBIA: ...

Knight Sells Priority Review Voucher to Gilead

MONTREAL, QUEBEC: ...

Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance

PRINCETON, NJ and REHOVOT, ISRAEL and BOTHELL, WA: Clinical Study Intended to Identify Novel microRNA Candidates for the Treatment of Duchenne Muscular Dystrophy ...

Marina Biotech Announces Third Quarter 2014 Financial Results

BOTHELL, WA: Highlights Corporate Accomplishments ...

Cleveland BioLabs and Roswell Park Cancer Institute Announce Publication of Studies Demonstrating Curaxin CBL0137''s Ability to Eradicate Drug-Resistant Cancer Stem Cells and Potentiate Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

BUFFALO, NY: ...

Knight Reports Third Quarter 2014 Results

MONTREAL, CANADA: ...